Catalyst Wire Dossier Catalyst Wire Dossier

Denikitug

GS-1811 · Gilead Sciences
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Denikitug, covering 2025-12-29 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas [Phase 2]

See pricing